Anavex Life Sciences Corp (AVXL)

[Investor2014]

As I said the abeta 42/40 performance is helpful and so are other biomarkers including MRI, the gene expression levels associated with AD/PDD that Missling also mentioned at Cowen etc. all as part of the peer reviewed publication, when eventually published. All that in combination with acceptance of the one co-primary and secondary outcome measures. Recall that Anavex is going for full approval rather than than the EMA equivalent of accelerated approval with confirmatory study, so the focus will be on the trials declared endpoints and SAP order.